We are live on ! Find out more
NGNE icon

Neurogene
NGNE

44 hedge funds and large institutions have $46.1M invested in Neurogene in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

0.86% less ownership

Funds ownership: 4.56% → 3.69% (-0.86%)

11% less call options, than puts

Call options by funds: $2.53M | Put options by funds: $2.83M

12% less funds holding

Funds holding: 50 → 44 (-6)

25% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 24

85% less capital invested

Capital invested by funds: $302M → $46.1M (-$255M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
44
Holders Change
-6
Holders Change %
-12%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
11
Reduced
9
Closed
24
Calls
$2.53M
Puts
$2.83M
Net Calls
-$308K
Net Calls Change
+$1.6M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$15M
2
PM
Prosight Management
Texas
+$5.22M
3
DAM
DLD Asset Management
New York
+$4.95M
4
HCM
Highbridge Capital Management
New York
+$3.76M
5
SFM
Sphera Funds Management
Israel
+$2.37M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$31.1M
2
Franklin Resources
Franklin Resources
California
-$18.9M
3
BC
Boxer Capital
California
-$10.5M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.04M
5
BlackRock
BlackRock
New York
-$6.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$29M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$3.58M -$31.1M -119,250 -64%
EC
3
EcoR1 Capital
California
$3.05M +$15M +57,500 New
PM
4
Prosight Management
Texas
$1.06M +$5.22M +20,045 New
DAM
5
DLD Asset Management
New York
$1.01M +$4.95M +18,995 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$882K +$223K +854 +5%
BlackRock
7
BlackRock
New York
$815K -$6.43M -24,660 -62%
HCM
8
Highbridge Capital Management
New York
$765K +$3.76M +14,431 New
SFM
9
Sphera Funds Management
Israel
$683K +$2.37M +9,104 +241%
UONDDL
10
University of Notre Dame du Lac
Indiana
$569K +$1M +3,845 +56%
EU
11
Emory University
Georgia
$554K +$391K +1,502 +17%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$440K +$284K +1,090 +15%
RA
13
Royce & Associates
New York
$385K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$330K +$1.62M +6,233 New
Millennium Management
15
Millennium Management
New York
$315K -$239K -918 -13%
OAM
16
Oxford Asset Management
United Kingdom
$299K +$1.01M +3,888 +168%
Northern Trust
17
Northern Trust
Illinois
$235K -$3.65K -14 -0.3%
KM
18
Kalos Management
Georgia
$226K – – –
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$193K – – –
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$151K – – –
Renaissance Technologies
21
Renaissance Technologies
New York
$151K +$741K +2,844 New
SM
22
Sabby Management
Florida
$146K +$719K +2,760 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$133K -$341K -1,307 -34%
BCM
24
Bridgeway Capital Management
Texas
$133K – – –
Squarepoint
25
Squarepoint
New York
$118K +$224K +858 +63%
1
2 3

NGNE Hedge Fund Activity: Q2 2018 in Review

44 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2018, worth a combined $46.1M — down 85% from $302M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of NGNE and 18 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $15M. The largest seller was T. Rowe Price Associates, cutting an estimated $31.1M.

  • 44 institutional investors held Neurogene (NGNE) as of Q2 2018, down from 50 in Q1 2018.
  • Funds reported $46.1M of Neurogene stock for Q2 2018, down 85% quarter-over-quarter.
  • 18 funds opened new Neurogene positions in Q2 2018 and 24 closed out, a net change of -6 holders.
  • The largest Neurogene buyer in Q2 2018 was EcoR1 Capital, an estimated $15M added.
  • The largest Neurogene seller in Q2 2018 was T. Rowe Price Associates, an estimated $31.1M sold.

Based on aggregated 13F filings for Q2 2018.